Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1

Interventions

Dexamethasone 45 Bortezomib 19 Lenalidomide 18 Calcium Dobesilate 18 Melphalan 16 Cyclophosphamide 11 pomalidomide 10 daratumumab 9 elotuzumab 8 carfilzomib 8 pembrolizumab 6 ixazomib 6 fludarabine phosphate 6 dexamethasone acetate 6 fludarabine 5 dexamethasone 21-phosphate 5 Filgrastim 5 venetoclax 4 selinexor 4 auricularum 4 Thalidomide 4 Tacrolimus 4 Peripheral Blood Stem Cell Transplantation 4 Magnetic Resonance Spectroscopy 4 liposomal doxorubicin 3 Whole-Body Irradiation 3 Vorinostat 3 Nivolumab 3 Mycophenolic Acid 3 Leukapheresis 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Multiple Myeloma × ferric pyrophosphate × Clear all

NCT03506802 2020-07-24

NYSCT MM

Jonsson Comprehensive Cancer Center

Phase 1 Withdrawn

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡